Genetic and epidemiological studies carried on numerous families in Asia, the United States, and Europe led to discover in 2004 that mutations in a new gene, known as leucine-rich repeat kinase 2 (LRRK2), are a key genetic risk factor for familiar and sporadic PD [1]. The gene discussed is LRRK2; the disease is Parkinson disease.